TLCR Reading Tools
How to cite item
Targeting MET and EGFR in NSCLC—what can we learn from the recently reported phase III trial of onartuzumab in combination with erlotinib in advanced non-small cell lung cancer?
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TLCR}{3116}, author = {Charakidis, M., Boyer, M.}, title = {Targeting MET and EGFR in NSCLC—what can we learn from the recently reported phase III trial of onartuzumab in combination with erlotinib in advanced non-small cell lung cancer?}, journal = {Translational Lung Cancer Research}, volume = {3}, number = {6}, year = {2014}, url = {https://tlcr.amegroups.org/article/view/3116} }